1.Benzodiazepine-Associated Carcinogenesis: Focus on Lorazepam-Associated Cancer Biomarker Changes in Overweight Individuals.
Shih Chieh KU ; Pei Shen HO ; Yu Ting TSENG ; Ta Chuan YEH ; Shu Li CHENG ; Chih Sung LIANG
Psychiatry Investigation 2018;15(9):900-906
OBJECTIVE: Cellular, animal, and human epidemiological studies suggested that benzodiazepines increase the risk of cancer and cancer mortality. Obesity is also clearly linked to carcinogenesis. However, no human studies have examined benzodiazepine-associated carcinogenesis as assessed by changes in cancer biomarkers. METHODS: A total of 19 patients were recruited, and received a 6-week treatment of 0.5 mg lorazepam. The measured cancer biomarkers were angiopoietin-2 (ANG-2), soluble CD40 ligand, epidermal growth factor, endoglin, soluble Fas ligand (sFASL), heparin-binding EGF-like growth factor (HB-EGF), insulin-like growth factor binding protein, interleukin (IL)-6, IL-8, IL-18, plasminogen activator inhibitor (PLGF), placental growth factor, transforming growth factor (TGF)-α, tumor necrosis factor (TNF)-α, urokinase-type plasminogen (uPA), vascular endothelial growth factor (VEGF)-A, VEGF-C, and VEGF-D. RESULTS: Six cancer biomarkers were significantly increased in all patients as a whole. The subgroup analysis revealed a distinct pattern of change. Overweight patients showed a significant increase in 11 cancer biomarkers, including ANG-2, sFASL, HB-EGF, IL-8, PLGF, TGF-α, TNF-α, uPA, VEGF-A, VEGF-C, and VEGF-D. However, normal-weight patients did not show any changes in cancer biomarkers. CONCLUSION: Adiposity may have primed the carcinogenic potential, leading to lorazepam-associated carcinogenesis in overweight patients. Epidemiological studies addressing this issue should consider the potential modulator contributing to benzodiazepine-associated carcinogenesis.
Adiposity
;
Angiopoietin-2
;
Animals
;
Benzodiazepines
;
Biomarkers, Tumor
;
Carcinogenesis*
;
Carrier Proteins
;
CD40 Ligand
;
Epidemiologic Studies
;
Epidermal Growth Factor
;
Fas Ligand Protein
;
Heparin-binding EGF-like Growth Factor
;
Humans
;
Interleukin-18
;
Interleukin-8
;
Interleukins
;
Lorazepam
;
Mortality
;
Obesity
;
Overweight*
;
Plasminogen
;
Plasminogen Activators
;
Transforming Growth Factors
;
Tumor Necrosis Factor-alpha
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factor C
;
Vascular Endothelial Growth Factor D
2.The regulating roles of angiopoietins/TEK-2 in angiogenesis.
Chinese Journal of Medical Genetics 2006;23(1):63-66
Angiopoietins(ANGPT) and their endothelial cell-specific tyrosine kinase receptors TEK are the major regulators of blood vessels angiogenesis under physiological and pathologic conditions. ANGPT1 is essentially involved in maturation, stabilization, and remodeling of blood vessels through inducing TEK autophosphorylation, promoting endothelial cell migration and survival. Instead, ANGPT2 appears to act as a natural antagonist of ANGPT1, it can activate vascular remodeling with the presence of vascular endothelial growth factor(VEGF) or regress frank blood vessels under the absence of VEGF. High expression of angiopoietins and TEK is often detected in tumor tissues. Many studies showed that disrupting the ANGPT/TEK receptor pathway could inhibit the growth of a number of murine tumors and human tumors. Thus, it is possible that inhibitors targeting the ANGPT/TEK pathway will have broad clinical utility to treatment of cancer.
Angiopoietin-1
;
physiology
;
Angiopoietin-2
;
physiology
;
Angiopoietins
;
physiology
;
Humans
;
Neovascularization, Physiologic
;
physiology
;
Receptor, TIE-2
;
physiology
3.Observation of the changes in ventral prostatic microcirculation in castrated rats.
Ru-Zhu LAN ; Zhang-Qun YE ; Rong-Jing DENG ; Shao-Gang WANG ; Chun-Lian CHEN ; Sheng ZHOU
National Journal of Andrology 2009;15(8):708-712
<b>OBJECTIVEb>Castrated rats exhibit significant shrinkage of the ventral prostate and apoptosis of prostatic cells, which can be attributed to the reduced blood supply to the prostate. But what causes the blood decrease in the prostate remains unknown. This study aims to explore the molecular mechanism of the changes in the microcirculation of the ventral prostate of rats following castration.
<b>METHODSb>We randomized 24 male adult rats into 6 groups of equal number, and collected their ventral prostates at 0, 1/2, 1, 2, 3 and 7 d, respectively, after castration. Then we observed the changes of the microvessels under the transmission electron microscope, detected the apoptosis of endothelial cells by TUNEL, and determined the expressions of VEGF, endostatin, angiostatin and angiopoietin-2 by Western blot.
<b>RESULTSb>The castrated rats showed dramatic changes in the microvessels of the ventral prostate, obvious apoptosis of the endothelial cells, down-regulated expression of VEGF, and up-regulated expressions of endostatin and angiostatin, while angiopoietin-2 remained unchanged.
<b>CONCLUSIONb>The decreased level of VEGF and increased levels of endostatin and angiostatin might underlie the mechanism of the changes in the microcirculation of the ventral prostate of rats following castration.
Angiopoietin-2 ; metabolism ; Angiostatins ; metabolism ; Animals ; Endostatins ; metabolism ; In Situ Nick-End Labeling ; Male ; Microcirculation ; Orchiectomy ; Prostate ; blood supply ; Rats ; Rats, Sprague-Dawley ; Vascular Endothelial Growth Factor A ; metabolism
4.Expression of Vascular Endothelial Growth Factors A,C and D in Gastric Adenocarcinoma.
Myoung Ja CHUNG ; Jin Wook LEE ; Ki Hoon YU ; Doo Hyun YANG ; Kyu Yun JANG ; Woo Sung MOON ; Myoung Jae KANG ; Dong Geun LEE
Korean Journal of Pathology 2005;39(2):99-105
BACKGROUND: Vascular endothelial growth factor (VEGF)-C and VEGF-D are novel growth factors that regulate lymphatic vessel growth. This study was designed to examine whether the expression of three VEGF family members, VEGF-A, VEGF-C and VEGF-D are associated with the clinicopathologic parameters, especially with lymph node metastasis, in advanced gastric carcinomas. METHODS: Immunohistochemical staining was performed for VEGF-A, VEGF-C, and VEGF-D in the surgically resected specimens from 102 patients with advanced gastric carcinoma. The mRNA expressions of the three VEGF family members were assessed in 16 cases of tumor tissues and their corresponding non-neoplastic tissues. RESULTS: Of the 102 gastric carcinomas, 74 (73%), 82 (80%), and 34 (33%) cases showed cytoplasmic immunoreactivity for VEGF-A, VEGF-C and VEGF-D, respectively. Both VEGF-A and VEGF-C expressions were associated with lymphatic invasion and lymph node metastasis (p<0.05), but the VEGF-D expression was not associated with them (p>0.05). In the tumor tissue, VEGF-C mRNA expression was greater, while VEGF-D mRNA expression was lower than in the nonneoplatic tissue adjacent to the tumor. CONCLUSIONS: VEGF-A and VEGF-C may play important roles for the lymphatic spread of gastric carcinoma. We suggest that neutralizing both VEGF-A and VEGF-C may be reguired to block lymph node metastasis.
Adenocarcinoma*
;
Cytoplasm
;
Humans
;
Intercellular Signaling Peptides and Proteins
;
Lymph Nodes
;
Lymphatic Vessels
;
Neoplasm Metastasis
;
RNA, Messenger
;
Vascular Endothelial Growth Factor A*
;
Vascular Endothelial Growth Factor C
;
Vascular Endothelial Growth Factor D
;
Vascular Endothelial Growth Factors*
5.Clinical Significance of Vascular Endothelial Growth Factors (VEGF)-C and -D in Resected Non-Small Cell Lung Cancer.
Yoon Ho KO ; Chan Kwon JUNG ; Myung Ah LEE ; Jae Ho BYUN ; Jin Hyoung KANG ; Kyo Young LEE ; Keon Hyun JO ; Young Pil WANG ; Young Seon HONG
Cancer Research and Treatment 2008;40(3):133-140
PURPOSE: Lymphatic spread of tumor is an important prognostic factor for patients with non-small cell lung carcinoma (NSCLC). Vascular endothelial growth factor-C (VEGF-C) and VEGF-D play important roles in lymphangiogenesis via the VEGF receptor 3 (VEGFR-3). We sought to determine whether VEGF-C, VEGF-D and VEGFR-3 are involved in the clinical outcomes of patients with resected NSCLC. MATERIALS AND METHODS: Using immunohistochemical staining, we investigated the protein expressions of VEGF-C, VEGF-D and VEGFR-3 in the tissue array specimens from patients who underwent resection for NSCLC. The immunoreactivity for p53 was also examined. The clinicopathological implications of these molecules were statistically analyzed. RESULTS: Analysis of a total of 118 specimens showed that VEGF-C, VEGF-D and their co-expression were significantly associated with more advanced regional lymph node metastasis (p=0.019, p=0.044 and p=0.026, respectively, N2 versus N0 and N1). A VEGFR-3 expression had a strong correlation with peritumoral lymphatic invasion (p=0.047). On the multivariate analysis for survival and recurrence, pathologic N2 lymph node metastasis was the only independent prognostic factor, but none of the investigated molecules showed any statistical correlation with recurrence and survival. CONCLUSIONS: The present study revealed that high expressions of VEGF-C and VEGF-D were strongly associated with more advanced regional lymph node metastasis in patients with resected NSCLC.
Carcinoma, Non-Small-Cell Lung
;
Humans
;
Lung
;
Lymph Nodes
;
Lymphangiogenesis
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Receptors, Vascular Endothelial Growth Factor
;
Recurrence
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factor C
;
Vascular Endothelial Growth Factor D
;
Vascular Endothelial Growth Factor Receptor-3
;
Vascular Endothelial Growth Factors
6.Expressions and Clinical Significances of Angiopoietin-1, Angiopoietin-2, and Tie-2 Receptor in Patients With Colorectal Cancer.
Sunghoon HONG ; Hae Il JUNG ; Tae Sung AHN ; Han Jo KIM ; Kyu Taek LEE ; Moo Jun BAEK ; Sang Byung BAE
Annals of Coloproctology 2017;33(1):9-15
PURPOSE: Angiopoietin-1 (Ang-1) plays a crucial role in vascular and hematopoietic development, mainly through its cognate receptor, Tie-2. Increased levels of Ang-2 have been shown to be correlated with abnormal tumor angiogenesis in several malignancies. Hence, we estimated the increased expression of Ang-2 relative to Ang-1 in patients with colorectal cancer and correlated our finding with prognosis in order to investigate the relationships between the expressions of Ang-1/Ang-2/Tie-2 receptor and the clinical parameters or overall survival of such patients. METHODS: We retrospectively analyzed 114 tissue samples from patients with colorectal cancer by using immunohistochemistry (IHC) to examine Ang-1, Ang-2, and Tie-2 expressions and to investigate the relationship between those expressions and clinical parameters or overall survival of such patients. A Western blot analysis was used for Ang-2 expression. RESULTS: IHC staining showed a link between Ang-1 and Tie-2 (P = 0.018), as well as meaningful correlations between Ang-2 and Tie-2 receptor (P = 0.022) and between lymph-node metastasis and Ang-2 (P = 0.025). The stronger the IHC staining for Ang-2 expression was, the shorter the cumulative survival was (P = 0.016). CONCLUSION: A relationship was found to exist between Ang-2 and Tie-2 expressions. The Ang-2 was correlated with lymph-node metastasis, and high expression of Ang-2 was indicative of poor overall survival. These findings suggest that Ang-2 is a useful prognostic marker in the management of patients with colorectal cancer. In addition, we suggest that Ang/Tie-2 signaling plays an important role in the progression of colorectal cancer.
Angiopoietin-1*
;
Angiopoietin-2*
;
Angiopoietins
;
Blotting, Western
;
Colorectal Neoplasms*
;
Humans
;
Immunohistochemistry
;
Neoplasm Metastasis
;
Prognosis
;
Receptor, TIE-2*
;
Retrospective Studies
7.Expression and significance of angiopoietins in oral squamous cell carcinoma.
Yun-xia WU ; Ping LIANG ; Xin-rong NAN ; Yan-jun JIAO ; Xiao-jun SUN
West China Journal of Stomatology 2005;23(1):63-68
<b>OBJECTIVEb>To observe the expression of angiopoietins in oral squamous cell carcinoma and relationship between the expression of angiopoietins and pathologic classification.
<b>METHODSb>The expression of Ang-1 and Ang-2 protein in samples from 42 oral squamous cell carcinoma and 16 oral normal mucosa were detected by immunohistochemical technique.
<b>RESULTSb>The expression of Ang-1 and Ang-2 was found in both oral squamous cell carcinoma and normal control. It was found Ang-1 expression alike in oral squamous cell carcinoma and control (P > 0.05). Ang-2 expressed at low level in control while strongly positive in oral squamous cell caroinoma and the level of Ang-2 expression in oral squamous cell caroinoma was related to pathologic classification (P < 0.05).
<b>CONCLUSIONb>Ang-2 expression in oral squamous cell carcinoma is related to angiogenesis and pathological classification, which is probably involved in angiogenesis regulation, promotes the development and metastasis of oral squamous cell carcinoma.
Angiopoietin-1 ; Angiopoietin-2 ; Angiopoietins ; Carcinoma, Squamous Cell ; Humans ; Male ; Middle Aged ; Mouth Mucosa ; Mouth Neoplasms ; Neoplasms ; Neovascularization, Pathologic
8.Expression of VEGFA, VEGFC, angiopoietin-1, angiopoietin-2 and their receptors on yolk sac blood island, aorta-gonad-mesonephros (AGM) region of human embryo.
Ji-Ying JIANG ; Ai-Dong LI ; Yan MEI ; Hong-Ying ZHOU ; Hui-Jun YANG ; Shu-Xia YANG ; Hua-Rong HONG ; Hong-Rui SONG
Journal of Experimental Hematology 2004;12(3):249-254
The study was to investigate the expression of VEGFA, VEGFC, angiopoietin-1, angiopoietin-2 and their receptors on yolk sac blood island, AGM region during gestation of 3th-12th weeks of human embryo. Human embryo contingently aborted at 3 - 12 weeks of gestation were collected with signed agreements of the pregnant women suffered from accidental abortions. The specimens were fixed by 4% paraformaldehyde and embedded by paraffin. 5 micro m serial sections were made. HE and immunohistochemistry method (SABC) and light-microscope were employed. The results showed that VEGFA and its receptors flt1/flk-1, VEGFC and its receptor flt-4, angiopoietin-2 and its receptor tie-2 proteins were expressed strongly and angiopoietin-1 was weakly expressed by hematopoietic cells and vascular endothelial cells of blood island at 21 and 25 days of gestation. In the 4th week of gestation, immuno-positive reaction of these factors and their receptors appeared in the aorta and mesonephros deposited in larger, rounded and nucleated cells which represented hematopoietic cells. Up to 7th week, positive hematopoietic cells in the regions were much abundant. The number of positive cells decreased at 8th week. Up to 12th week, almost all blood cells were immuno-negative. VEGFA, flt-1, flt-4, angiopoietin-1, angiopoietin-2 and Tie-2 protein were expressed mainly by gonad at 6 - 8 weeks, but it did not express VEGFC and flk-1. The immuno-reaction of the factors and their receptors could not detected in vascular endothelial cells during 3-12th weeks of gestation. It is concluded that hematopoietic cells and endothelial cells in blood island of yolk sac, mesonephros and dorsal aorta co-expressed some factors and their receptors in relation to vasculogenesis and hematopoiesis. Intraembryonic hematopoiesis began in the 4th week of gestation.
Angiopoietin-1
;
analysis
;
Angiopoietin-2
;
analysis
;
Embryo, Mammalian
;
chemistry
;
Extracellular Matrix Proteins
;
analysis
;
Humans
;
Immunohistochemistry
;
Receptor, TIE-2
;
analysis
;
Receptors, Vascular Endothelial Growth Factor
;
analysis
;
Vascular Endothelial Growth Factor A
;
analysis
;
Vascular Endothelial Growth Factor C
;
analysis
;
Vascular Endothelial Growth Factor Receptor-1
;
Vascular Endothelial Growth Factor Receptor-2
;
analysis
;
Vascular Endothelial Growth Factor Receptor-3
;
analysis
;
Yolk Sac
;
chemistry
9.Comparative immunohistochemical assays for the expression of angiogenic factors in tumors of human salivary glands
Yeon Soo IN ; Soung Min KIM ; Young Wook PARK
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 2007;29(1):10-23
vascular metastasis and poor responses to classical chemotherapeutic agents. Poor prognoses from salivary ACC are caused by lung metastases that are resistant to conventional therapy. Therefore, cellular and molecular characteristics that influence the dissemination of metastatic cells are important for the design of more effective treatment of salivary ACC. Tumor angiogenesis has been known to be essential for the distant metastasis of malignant cells. So, we determined expressions of angiogenic proteins in benign (pleomorphic adenoma) and malignant (ACC, mucoepidermoid carcinoma) tumors of salivary glands and compared each other and to those in oral squamous cell carcinoma. Using surgical specimens, we performed immunohistochemical assays with anti-vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2), phosphorylated VEGFR-2 (pVEGFR-2), matrix metalloproteinase (MMP)-9, and interleukin (IL)-8 antibodies. Most angiogenic factors were overexpressed in malignant salivary tumors than in pleomorphic adenoma which is benign nature. Moreover, ACC demonstrated more expression of VEGFR-2 than that of squamous cell carcinoma which used as control. Conclusively, these data show those angiogenic factors produced by salivary gland tumors may affect the propagation and metastasis of malignant cells of salivary tumors, and could be used as biomarkers for the malignant transformation of salivary gland tumors. Prospectively, although further studies will be needed, these biomarkers related to angiogenesis can be molecular targets for the therapy of salivary ACC, which has propensity for delayed vascular metastasis.]]>
Adenoids
;
Adenoma, Pleomorphic
;
Angiogenesis Inducing Agents
;
Angiogenic Proteins
;
Antibodies
;
Biomarkers
;
Carcinoma, Adenoid Cystic
;
Carcinoma, Squamous Cell
;
Endothelial Growth Factors
;
Humans
;
Interleukins
;
Lung
;
Neoplasm Metastasis
;
Prognosis
;
Salivary Glands
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factor Receptor-2
10.Expression of VEGFA, VEGFC, angiopoietin-1, angiopoietin-2 and their receptors on development liver during gestation of weeks 3-12 of human embryo.
Yan MEI ; Ai-Dong LI ; Ji-Ying JIANG ; Hong-Ying ZHOU ; Hui-Jun YANG ; Shu-Xia YANG ; Hua-Rong HONG ; Hong-Rui SONG
Journal of Experimental Hematology 2004;12(5):632-636
The aim was to study the expression of VEGF-A, VEGF-C, angiopoietin-1, angiopoietin-2 and their receptors on development liver during gestation of weeks 3-12 of human embryo. Human embryo contingently aborted at 3-12 weeks of gestation were collected with signed agreements of the pregnant women suffered from accidental abortions. The specimens were fixed by 4% paraformaldehyde and embedded by paraffin. 5 microm serial sections were made. HE staining, immunohistochemistry method and light-microscope were employed. The results showed that at 4-5 weeks of development, liver was constituted by a few hepatic cords. Hematopoietic cell or blood cells were undetectable in the 4 week of gestation. A few cells which were larger, rounded and nucleared cells appeared and expressed VEGFA, flt-4 and Tie-2 proteins strongly in liver at 5 weeks of gestation. The number of these immuno-positive cells was highest in the 7th week and decreased at 11-12 weeks of gestation. These cells expressed flk-1 transiently in the 6th week. VEGF-C and flt-1 were expressed by hepatic cells from weeks 7 to 12 of gestation. The immuno-positive products were deposited in plasma of hepatic cells. Angiopoietin-1, angiopoietin-2 and Tie-2 were detectable on those cells which expressed VEGFA, flt-4 and Tie-2 from weeks 5 to 12 of gestation. The expression of angiopoietin-1 and angiopoietin-2 were weakly and Tie-2 was strongly. They were expressed weakly too by hepatic cells at 5 to 12 weeks of gestation. All factors and their receptors were undetectable on vascular endothelial cells at 4-12 weeks of gestation. It is concluded that the expression patterns of VEGF family on cells of liver are different before and after 7 weeks of gestation. The hematopoiesis in fetal liver may be related to development of hepatic cell.
Angiopoietin-1
;
analysis
;
Angiopoietin-2
;
analysis
;
Extracellular Matrix Proteins
;
analysis
;
Female
;
Gestational Age
;
Humans
;
Immunohistochemistry
;
Liver
;
chemistry
;
embryology
;
Pregnancy
;
Receptor, TIE-2
;
analysis
;
Vascular Endothelial Growth Factor A
;
analysis
;
Vascular Endothelial Growth Factor C
;
analysis
;
Vascular Endothelial Growth Factor Receptor-1
;
Vascular Endothelial Growth Factor Receptor-3
;
analysis